EDA
The article highlights the key points related to the regulatory framework for clinical trials in Egypt.
EDA
The article describes in detail the matters related to the objectives of clinical trials, as well as the applicable regulatory oversight.
EDA
The new article outlines the key points to be addressed when initiating a clinical investigation, as well as upon its completion.
EDA
The new article provides additional clarifications regarding various specific aspects to be taken into consideration by the parties responsible for clinical investigations intended to be conducted in Egypt.
FDA
The article highlights the key points associated with the use-related risk analyses to be conducted with respect to various healthcare products intended to be marketed and used in the US.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report
